» Articles » PMID: 35598103

Stability and Reproducibility of Proteomic Profiles in Epidemiological Studies: Comparing the Olink and SOMAscan Platforms

Abstract

Limited data exist on the performance of high-throughput proteomics profiling in epidemiological settings, including the impact of specimen collection and within-person variability over time. Thus, the Olink (972 proteins) and SOMAscan7Kv4.1 (7322 proteoforms of 6596 proteins) assays were utilized to measure protein concentrations in archived plasma samples from the Nurses' Health Studies and Health Professionals Follow-Up Study. Spearman's correlation coefficients (r) and intraclass correlation coefficients (ICCs) were used to assess agreement between (1) 42 triplicate samples processed immediately, 24-h or 48-h after blood collection from 14 participants; and (2) 80 plasma samples from 40 participants collected 1-year apart. When comparing samples processed immediately, 24-h, and 48-h later, 55% of assays had an ICC/r ≥ 0.75 and 87% had an ICC/r ≥ 0.40 in Olink compared to 44% with an ICC/r ≥ 0.75 and 72% with an ICC/r ≥ 0.40 in SOMAscan7K. For both platforms, >90% of the assays were stable (ICC/r ≥ 0.40) in samples collected 1-year apart. Among 817 proteins measured with both platforms, Spearman's correlations were high (r > 0.75) for 14.7% and poor (r < 0.40) for 44.8% of proteins. High-throughput proteomics profiling demonstrated reproducibility in archived plasma samples and stability after delayed processing in epidemiological studies, yet correlations between proteins measured with the Olink and SOMAscan7K platforms were highly variable.

Citing Articles

Serum Olink Targeted Proteomics Identifies IL-17A as a Prospective Inflammatory Marker for the Prediction and Diagnosis of Kawasaki Disease.

Tu X, Chen X, Xu L, Yang C, Li J, Liu Y J Inflamm Res. 2025; 18:3093-3103.

PMID: 40059947 PMC: 11889999. DOI: 10.2147/JIR.S506154.


Cross-Ancestry Comparison of Aptamer and Antibody Proteomics Measures.

Raffield L, Nicholas J, Katz D, Nicholas J, Tahir U, Katz D Res Sq. 2025; .

PMID: 39989965 PMC: 11844639. DOI: 10.21203/rs.3.rs-5968391/v1.


Comparative studies of 2168 plasma proteins measured by two affinity-based platforms in 4000 Chinese adults.

Wang B, Pozarickij A, Mazidi M, Wright N, Yao P, Said S Nat Commun. 2025; 16(1):1869.

PMID: 39984443 PMC: 11845630. DOI: 10.1038/s41467-025-56935-2.


Novel inflammatory markers in intracerebral hemorrhage: Results from Olink proteomics analysis.

Hu Z, Chen S, Zhang E, Wei L, Wang J, Shang Q FASEB J. 2025; 39(2):e70341.

PMID: 39853806 PMC: 11760662. DOI: 10.1096/fj.202402183RR.


Longitudinal serum proteome mapping reveals biomarkers for healthy ageing and related cardiometabolic diseases.

Tang J, Yue L, Xu Y, Xu F, Cai X, Fu Y Nat Metab. 2025; 7(1):166-181.

PMID: 39805987 PMC: 11774760. DOI: 10.1038/s42255-024-01185-7.


References
1.
Mallick P, Kuster B . Proteomics: a pragmatic perspective. Nat Biotechnol. 2010; 28(7):695-709. DOI: 10.1038/nbt.1658. View

2.
Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen S, Ekman D . Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014; 9(4):e95192. PMC: 3995906. DOI: 10.1371/journal.pone.0095192. View

3.
Hankinson S, Willett W, Manson J, Colditz G, Hunter D, Spiegelman D . Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998; 90(17):1292-9. DOI: 10.1093/jnci/90.17.1292. View

4.
Geyer P, Holdt L, Teupser D, Mann M . Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol. 2017; 13(9):942. PMC: 5615924. DOI: 10.15252/msb.20156297. View

5.
Walker M, Song R, Xu X, Gerszten R, Ngo D, Clish C . Proteomic and Metabolomic Correlates of Healthy Dietary Patterns: The Framingham Heart Study. Nutrients. 2020; 12(5). PMC: 7284467. DOI: 10.3390/nu12051476. View